Publicacións nas que colabora con Manuel Rodríguez López (2)

2022

  1. Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products

    Thrombosis Research, Vol. 216, pp. 35-42

2020

  1. Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain

    BMJ Case Reports, Vol. 13, Núm. 10